The company is seeking a Director of Market Access for Switzerland to lead reimbursement strategies, negotiate with payers, and ensure patient access to innovative oncology therapies in the Basel region.
This role focuses on defining and executing the market access strategy for Switzerland to guarantee timely and sustainable patient access to the company's oncology treatments. The position is responsible for shaping reimbursement approaches, demonstrating clinical and economic value, and managing relationships with key external stakeholders such as payers and health technology assessment bodies.
Responsibilities
- Formulate and execute strategies to facilitate access and pricing decisions for the company's portfolio within the Swiss healthcare framework.
- Oversee the creation and submission of value dossiers, manage benefit assessments, and lead pricing negotiations with statutory health insurance authorities.
- Collaborate with Medical Affairs and Marketing teams to adapt clinical and economic evidence into persuasive value communications for Swiss payers.
- Establish and sustain robust relationships with external stakeholders, including payers, HTA authorities, and policy influencers.
- Coordinate with regional and Midsized Markets teams to ensure local strategies align with broader European and corporate goals.
- Provide early market access insights to regional and European clinical development and medical teams.
- Lead negotiations with national payers at all levels.
- Create innovative pricing and value-based contracting models to expedite reimbursement approvals.
- Track health policy changes, HTA processes, and local reimbursement landscapes to inform strategic decisions.
- Represent the Market Access function in Switzerland Leadership Team meetings and contribute to overall business strategy.
- Manage access and value-related projects, including landscape assessments, payer market research, advisory boards, and local strategy guidance.
- Develop and maintain an outreach and engagement plan for key payers to build a strong network.
Requirements
- At least 10 years of experience in market access, pricing, reimbursement, or health economics within the Swiss pharma or biotech sector.
- Proven experience in value and benefit assessments, with a deep understanding of Swiss payer decision-making processes.
- Demonstrated success in supporting oncology product pre-launch, launch, and post-launch activities in Switzerland.
- Track record of negotiating pricing and reimbursement conditions with public administrations and health authorities.
- Strong stakeholder management skills and ability to collaborate with internal and external partners.
- Excellent interpersonal and communication skills.
- Scientific and solution-oriented mindset with the ability to execute in a rapidly changing, ambiguous environment.
- Deep understanding of the local healthcare system, customer dynamics, and reimbursement environments.
- Experience working in a biotech company or during a build-out phase.
- High social competence for teamwork, coaching, and situational leadership.
About the company
Revolution Medicines is a late-stage clinical oncology company dedicated to developing novel targeted therapies for patients with RAS-addicted cancers. The company maintains a tireless commitment to improving outcomes for patients with cancers harboring mutations in the RAS signaling pathway.
Quelle: öffentlich zugängliche Karriereseite des Arbeitgebers. Batchly ist nicht der Arbeitgeber und steht nicht notwendigerweise in einem Vertragsverhältnis mit dem Unternehmen.